EBS
Emergent BioSolutions Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-27
Figures on this page computed 2026-11-08 12:12 UTC
Last close
5.90USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-27
6.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
7.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
21.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.32 against 0.47 on the market's range.
- Growth-14.0%32 of 100, below its sector
- Returns on capital10.1%69 of 100, above its sector
- Margins56.1%75 of 100, above its sector
- Price6.2x84 of 100, above its sector
- Safety5.0147 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9What it sells
2Where it sells it
3Who it sells it to
1Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
2 segments, 3 places and 1 named customers, each as the filer published it.
2 segments, 3 places and 1 named customers, each as the filer published it.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-27
MCM Products Segment456,700,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Commercial Products Segment226,100,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
UNITED STATES531,100,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Other Geographical Area136,800,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
CANADA75,000,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
United States Government46.0%
- Source
- filed
- Statement
- concentration
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015